{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:01:09Z","timestamp":1787162469344,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Department of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14047-6","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:28:52Z","timestamp":1744612132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors for radiation-induced rib fractures following proton beam therapy for stage I non-small cell lung cancer: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3236-7440","authenticated-orcid":false,"given":"Naoaki","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-4336","authenticated-orcid":false,"given":"Takashi","family":"Yoshiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Kakinohana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"14047_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijrobp.2019.09.013","volume":"106","author":"K Ohnishi","year":"2020","unstructured":"Ohnishi K, Nakamura N, Harada H, Tokumaru S, Wada H, Arimura T, et al. Proton beam therapy for histologically or clinically diagnosed stage I non-small cell lung cancer (NSCLC): the first nationwide retrospective study in Japan. Int J Radiat Oncol Biol Phys. 2020;106:82\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14047_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ijrobp.2005.05.034","volume":"63","author":"Y Nagata","year":"2005","unstructured":"Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, et al. Clinical outcomes of a phase I\/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14047_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","volume":"93","author":"Y Nagata","year":"2015","unstructured":"Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan clinical oncology group study JCOG0403. Int J Radiat Oncol Biol Phys. 2015;93:989\u201396.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14047_CR4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3390\/cancers14092271","volume":"14","author":"A Santos","year":"2022","unstructured":"Santos A, Penfold S, Gorayski P, Le H. The role of hypofractionation in proton therapy. Cancers. 2022;14:2271.","journal-title":"Cancers"},{"key":"14047_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1748-717X-7-159","volume":"7","author":"M Taremi","year":"2012","unstructured":"Taremi M, Hope A, Lindsay P, Dahele M, Fung S, Purdie TG, et al. Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy. Radiat Oncol. 2012;7:159.","journal-title":"Radiat Oncol"},{"key":"14047_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.lungcan.2012.10.011","volume":"79","author":"SS Kim","year":"2013","unstructured":"Kim SS, Song SY, Kwak J, Ahn SD, Kim JH, Lee JS, et al. Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors. Lung Cancer. 2013;79:161\u20136.","journal-title":"Lung Cancer"},{"key":"14047_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ijrobp.2012.01.027","volume":"84","author":"K Asai","year":"2012","unstructured":"Asai K, Shioyama Y, Nakamura K, Sasaki T, Ohga S, Nonoshita T, et al. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship. Int J Radiat Oncol Biol Phys. 2012;84:768\u201373.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14047_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.radonc.2017.01.004","volume":"123","author":"B Stam","year":"2017","unstructured":"Stam B, van der Bijl E, Peulen H, Rossi MMG, Belderbos JSA, Sonke JJ. Dose\u2013effect analysis of radiation induced rib fractures after thoracic SBRT. Radiother Oncol. 2017;123:176\u201381.","journal-title":"Radiother Oncol"},{"key":"14047_CR9","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/j.prro.2019.01.012","volume":"9","author":"C Chipko","year":"2019","unstructured":"Chipko C, Ojwang J, Gharai LR, Deng X, Mukhopadhyay N, Weiss E. Characterization of chest wall toxicity during long-term follow up after thoracic stereotactic body radiation therapy. Pract Radiat Oncol. 2019;9:e338\u201346.","journal-title":"Pract Radiat Oncol"},{"key":"14047_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2407-13-68","volume":"13","author":"A Nambu","year":"2013","unstructured":"Nambu A, Onishi H, Aoki S, Tominaga L, Kuriyama K, Araya M, et al. Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors. BMC Cancer. 2013;13:68.","journal-title":"BMC Cancer"},{"key":"14047_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/jrr\/rru107","volume":"56","author":"H Miura","year":"2015","unstructured":"Miura H, Inoue T, Shiomi H, Oh RJ. Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for stage I primary lung cancer. J Radiat Res. 2015;56:332\u20137.","journal-title":"J Radiat Res"},{"key":"14047_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13014-015-0406-8","volume":"10","author":"M Aoki","year":"2015","unstructured":"Aoki M, Sato M, Hirose K, Akimoto H, Kawaguchi H, Hatayama Y, et al. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54\u201356 Gy given in 9\u2013\u20097 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size. Radiat Oncol. 2015;10:99.","journal-title":"Radiat Oncol"},{"key":"14047_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12885-023-10776-8","volume":"23","author":"MP Carducci","year":"2023","unstructured":"Carducci MP, Sundaram B, Greenberger BA, Werner-Wasik M, Kane GC. Predictors and characteristics of rib fracture following SBRT for lung tumors. BMC Cancer. 2023;23:337.","journal-title":"BMC Cancer"},{"key":"14047_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.clon.2015.06.009","volume":"28","author":"I Thibault","year":"2016","unstructured":"Thibault I, Chiang A, Erler D, Yeung L, Poon I, Kim A, et al. Predictors of chest wall toxicity after lung stereotactic ablative radiotherapy. Clin Oncol. 2016;28:28\u201335.","journal-title":"Clin Oncol"},{"key":"14047_CR15","first-page":"100683","volume":"43","author":"N Kita","year":"2023","unstructured":"Kita N, Tomita N, Takaoka T, Matsuura A, Okazaki D, Niwa M, et al. Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Clin Transl Radiat Oncol. 2023;43:100683.","journal-title":"Clin Transl Radiat Oncol"},{"key":"14047_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1620\/tjem.238.339","volume":"238","author":"Y Ishikawa","year":"2016","unstructured":"Ishikawa Y, Nakamura T, Kato T, Kadoya N, Suzuki M, Azami Y, et al. Dosemetric parameters predictive of rib fractures after proton beam therapy for early-stage lung cancer. Tohoku J Exp Med. 2016;238:339\u201345.","journal-title":"Tohoku J Exp Med"},{"key":"14047_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/0284186X.2015.1088169","volume":"55","author":"T Abe","year":"2016","unstructured":"Abe T, Shirai K, Saitoh JI, Ebara T, Shimada H, Tashiro M, et al. Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer. Acta Oncol. 2016;55:163\u20136.","journal-title":"Acta Oncol"},{"key":"14047_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3109\/0284186X.2012.718094","volume":"52","author":"A Kanemoto","year":"2013","unstructured":"Kanemoto A, Mizumoto M, Okumura T, Takahashi H, Hashimoto T, Oshiro Y, et al. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma. Acta Oncol. 2013;52:538\u201344.","journal-title":"Acta Oncol"},{"key":"14047_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2020.03.012","volume":"107","author":"CC Wang","year":"2020","unstructured":"Wang CC, McNamara AL, Shin J, Schuemann J, Grassberger C, Taghian AG, et al. End-of-range Radiobiological effect on rib fractures in patients receiving proton therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2020;107:449\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14047_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.14338\/IJPT-22-00034.1","volume":"9","author":"JA Bradley","year":"2023","unstructured":"Bradley JA, Liang X, Mailhot Vega RB, Liu C, Brooks ED, Burchianti T, et al. Incidence of rib fracture following treatment with proton therapy for breast cancer. Int J Part Ther. 2023;9:269\u201378.","journal-title":"Int J Part Ther"},{"key":"14047_CR21","first-page":"1161","volume":"52","author":"T Inada","year":"1992","unstructured":"Inada T, Tsuji H, Hayakawa Y, Maruhashi A, Tsujii H. Proton irradiation synchronized with respiratory cycle. Nihon Igaku Hoshasen Gakkai Zasshi. 1992;52:1161\u20137.","journal-title":"Nihon Igaku Hoshasen Gakkai Zasshi"},{"key":"14047_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/JTO.0000000000000435","volume":"10","author":"K Huang","year":"2015","unstructured":"Huang K, Palma DA. Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist. J Thorac Oncol. 2015;10:412\u20139.","journal-title":"J Thorac Oncol"},{"key":"14047_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3389\/fonc.2020.00742","volume":"10","author":"G Yaprak","year":"2020","unstructured":"Yaprak G, Gemici C, Seseogullari OO, Karabag IS, Cini N. CT derived Hounsfield unit: an easy way to determine osteoporosis and radiation related fracture risk in irradiated patients. Front Oncol. 2020;10:742.","journal-title":"Front Oncol"},{"key":"14047_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP van Staa","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13:777\u201387.","journal-title":"Osteoporos Int"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14047-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:28:53Z","timestamp":1744612133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14047-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14047"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14047-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Information about this study was posted at the study site and on the institutional website (\n                      \n                      ), ensuring that patients had the opportunity to opt out of participation at any time during the research period. As the study utilized only existing data, individual consent from participants was deemed unnecessary according to the national guideline (Ethical Guidelines for Medical and Biological Research Involving Human Subjects). This study was approved by the ethics committee of the Medipolis Proton Therapy and Research Center on November 10, 2021, and adhered to the Declaration of Helsinki (reference number: R2021-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"682"}}